Key Highlights
- Sue Ann Pentecost takes on the role of Vice President, Head of Pharmaceuticals Communications in the U.S., reporting to Beth Roden.
- Brings over 25 years of experience in health care communications, including a pivotal role in U.S. Oncology communications at Bayer.
- Acknowledged for innovative thinking and leadership, Pentecost is set to enhance Bayer’s reputation and support U.S. Pharmaceuticals business and brands.
Source: Business Wire
Notable Quotes
- “I am delighted to have Sue Ann step into this role. She has a breadth of experience across all facets of Communications, is a valued leader and colleague, and brings innovative thinking that will be key as we help position Bayer for long-term success,” – Beth Roden, Senior Vice President, Head of Communications at Bayer U.S
- “Communication is a critical function, and I’m honored to take on this leadership role during such a pivotal time of growth for Bayer’s U.S. Pharmaceuticals business,” – Sue Ann Pentecost, Vice President, Head of Pharmaceuticals Communications at Bayer U.S.
SoHC's Take
Bayer’s strategic appointment of Sue Ann Pentecost as Vice President, Head of Pharmaceuticals Communications, marks a significant leadership transition aimed at further bolstering the company’s communication strategies and reputation in the healthcare sector. Pentecost’s extensive background in health care communications and her innovative approach to oncology campaigns reflect Bayer’s commitment to leadership excellence and strategic communication. With a history of driving growth and enhancing brand reputation, her role is crucial in navigating the complexities of the healthcare industry and advancing Bayer’s mission of “Health for all, Hunger for none.” This leadership change occurs at a time of considerable transformation for Bayer, emphasizing the company’s focus on innovation, sustainability, and global health initiatives.
